415 related articles for article (PubMed ID: 31681629)
21. Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.
Doi AM; Pignatari AC; Edmond MB; Marra AR; Camargo LF; Siqueira RA; da Mota VP; Colombo AL
PLoS One; 2016; 11(1):e0146909. PubMed ID: 26808778
[TBL] [Abstract][Full Text] [Related]
22. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.
Pfaller MA; Moet GJ; Messer SA; Jones RN; Castanheira M
Antimicrob Agents Chemother; 2011 Feb; 55(2):561-6. PubMed ID: 21115790
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.
Bassetti M; Merelli M; Righi E; Diaz-Martin A; Rosello EM; Luzzati R; Parra A; Trecarichi EM; Sanguinetti M; Posteraro B; Garnacho-Montero J; Sartor A; Rello J; Tumbarello M
J Clin Microbiol; 2013 Dec; 51(12):4167-72. PubMed ID: 24108614
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Wang H; Xu YC; Hsueh PR
Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
[TBL] [Abstract][Full Text] [Related]
25. Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010-2019: A retrospective observational study based on national surveillance data.
Kajihara T; Yahara K; Nagi M; Kitamura N; Hirabayashi A; Hosaka Y; Abe M; Miyazaki Y; Sugai M
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36095139
[TBL] [Abstract][Full Text] [Related]
26. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region.
Tan TY; Hsu LY; Alejandria MM; Chaiwarith R; Chinniah T; Chayakulkeeree M; Choudhury S; Chen YH; Shin JH; Kiratisin P; Mendoza M; Prabhu K; Supparatpinyo K; Tan AL; Phan XT; Tran TT; Nguyen GB; Doan MP; Huynh VA; Nguyen SM; Tran TB; Van Pham H
Med Mycol; 2016 Jul; 54(5):471-7. PubMed ID: 26868904
[TBL] [Abstract][Full Text] [Related]
27. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
Breda GL; Tuon FF; Meis JF; Herkert PF; Hagen F; de Oliveira LZ; Dias VC; da Cunha CA; Queiroz-Telles F
Med Mycol; 2018 Jun; 56(4):406-415. PubMed ID: 29420820
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of PNA-FISH method for direct identification of Candida species in blood culture samples and its potential impact on guidance of antifungal therapy].
Doğan Ö; İnkaya AÇ; Gülmez D; Uzun Ö; Akova M; Arıkan Akdağlı S
Mikrobiyol Bul; 2016 Oct; 50(4):580-589. PubMed ID: 28124963
[TBL] [Abstract][Full Text] [Related]
29. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
[TBL] [Abstract][Full Text] [Related]
30. Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.
Ma CF; Li FQ; Shi LN; Hu YA; Wang Y; Huang M; Kong QQ
BMC Infect Dis; 2013 Jul; 13():337. PubMed ID: 23875950
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
[TBL] [Abstract][Full Text] [Related]
32. Study of Candidemia and its Antifungal Susceptibility Profile at the University Hospital of Montevideo, Uruguay.
Carbia M; Medina V; Bustillo C; Martínez C; González MP; Ballesté R
Mycopathologia; 2023 Dec; 188(6):919-928. PubMed ID: 37314581
[TBL] [Abstract][Full Text] [Related]
33. Changing epidemiology of candidaemia in Australia.
Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S;
J Antimicrob Chemother; 2017 Apr; 72(4):1103-1108. PubMed ID: 28364558
[TBL] [Abstract][Full Text] [Related]
34. Impact on Antifungal Susceptibility Patterns of Previous vs. Revised Clinical and Laboratory Standards Institute Breakpoints for Candida Species Isolated from Candidemia: Experience of Two Tertiary Care Institutions in Japan.
Hirano R; Minakawa S; Kitazawa J; Saito N; Kayaba H
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307163
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of candidemia in NICE area, France: A five-year study of antifungal susceptibility and mortality.
Vannini M; Emery S; Lieutier-Colas F; Legueult K; Mondain V; Retur N; Gastaud L; Pomares C; Hasseine L
J Mycol Med; 2022 Mar; 32(1):101210. PubMed ID: 34768155
[TBL] [Abstract][Full Text] [Related]
36. Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections.
Deorukhkar SC; Saini S
Infect Disord Drug Targets; 2016; 16(1):63-8. PubMed ID: 26648186
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period.
Mencarini J; Mantengoli E; Tofani L; Riccobono E; Fornaini R; Bartalesi F; Corti G; Farese A; Pecile P; Boni L; Rossolini GM; Bartoloni A
Infection; 2018 Aug; 46(4):469-476. PubMed ID: 29654496
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
39. The emergence of non-albicans candidemia and evaluation of HiChrome Candida differential agar and VITEK2 YST® platform for differentiation of Candida bloodstream isolates in teaching hospital Kandy, Sri Lanka.
Kothalawala M; Jayaweera JAAS; Arunan S; Jayathilake A
BMC Microbiol; 2019 Jun; 19(1):136. PubMed ID: 31226938
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: A six-year retrospective study.
Medeiros MAP; Melo APV; Bento AO; Souza LBFC; Neto FAB; Garcia JB; Zuza-Alves DL; Francisco EC; Melo ASA; Chaves GM
PLoS One; 2019; 14(8):e0221033. PubMed ID: 31437188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
